Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE-1: Gepotidacin vs Standard of Care for Uncomplicated Urogenital Gonorrhea
NCT04010539Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2019
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of gepotidacin in gonorrhea (GC), sponsored by GSK. Started Oct 2019; status: completed.
02
Drugs
gepotidacin
03
Conditions
gonorrhea (GC)
Beyond the preview
Go deeper on NCT04010539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04010539.